LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
NASDAQ:LMAT
Price:
75 USD
-1.19%
Market Closed
Updated:
May 9, 2024
LeMaitre Vascular Inc
Income from Continuing Operations
|
LeMaitre Vascular Inc
Income from Continuing Operations Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Income from Continuing Operations
$34m
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
32%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is LeMaitre Vascular Inc's Income from Continuing Operations?
Income from Continuing Operations
34m
USD
34m
USD
Based on the financial report for Mar 31, 2024, LeMaitre Vascular Inc's Income from Continuing Operations amounts to 34m USD.
What is LeMaitre Vascular Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
32%
32%
Over the last year, the Income from Continuing Operations growth was 64%. The average annual Income from Continuing Operations growth rates for LeMaitre Vascular Inc have been 12% over the past three years , 8% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
